Dable Habib J

CEO and President, DirectorACCELERON PHARMA INC (XLRN) · full profile →Form 4 · filed Jul 2, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$12.7M
Net Open-Market Flow
-$12.7M
Transactions
12
10 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 2, 2021Sell(S)11K$127.51$1.5M100K
Jul 2, 2021Sell(S)29K$126.69$3.7M111K
Jul 2, 2021Option exercise(M)42K$35.04$1.5M141K
Jul 2, 2021Sell(S)2K$128.21$204K98K
Jul 1, 2021Sell(S)9K$125.81$1.2M135K
Jul 1, 2021Option exercise(M)58K$35.04$2.0M156K
Jul 1, 2021Sell(S)12K$125.15$1.5M144K
Jul 1, 2021Sell(S)9K$128.82$1.2M98K
Jul 1, 2021Sell(S)5K$127.89$583K108K
Jul 1, 2021Sell(S)23K$126.85$2.9M112K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 2, 2021Option exercise(M)42K$0250K
Jul 1, 2021Option exercise(M)58K$0292K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001179110-21-007353) within minutes of acceptance. Every field above traces to the original document. Verify it directly: